fda drug safety communication semaglutide naion 2025 Since 2025, lawsuits have been increasing over claims Ozempic may trigger NAION, an “eye stroke” that blocks blood flow to the optic nerve and can cause sudden, painless, permanent blindness. #MadameNoireHeadlines Nestlé's GLP-1 strategy reframes dietary:gluten-free Size:Semaglutide 1mg

fda drug safety communication semaglutide naion 2025 Since 2025, lawsuits have been increasing over claims Ozempic may trigger NAION, an “eye stroke” that blocks blood flow to the optic nerve and can cause sudden, painless, permanent blindness. #MadameNoireHeadlines Nestlé's GLP-1 strategy reframes dietary:gluten-free Size:Semaglutide 1mg

Nestlé's GLP-1 strategy reframes food formulation around nutrient density

This might include switching to another GLP-1 receptor agonist, adding or adjusting other oral hypoglycaemic agents, or considering injectable therapies such as insulin if appropriate, in line with NICE guidance (NG28)

dietary:gluten-free

Size:Semaglutide 1mg

CVOTs In response to FDA guidelines requiring the assessment of anti-diabetic therapeutics in relation to cardiovascular risk, several CVOTs have been performed